Outline current approaches and guideline-directed strategies for the management of IBD
|
|
|
|
|
|
Assess the evidence base on early intervention with biologic agents for patients at risk for a complicated disease course
|
|
|
|
|
|
Evaluate pivotal clinical trial data and real-world studies of new and emerging agents for the treatment of IBD
|
|
|
|
|
|
Analyze challenging patient cases to identify alternate clinical approaches and enhance patient outcomes for IBD
|
|
|
|
|
|